FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

20 Jan 15

Cancer Genetics, Inc. Launches Digital Platform to Enable Collaboration With Community Hospitals and Laboratories (read more...)

- RUTHERFORD, N.J., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc., (Nasdaq:CGIX) ("CGI" or "the company"), an emerging leader in DNA-based (read more...)
05 Jan 15

Cancer Genetics, Inc. Receives Approval to Provide Oncology Testing for Patients in California (read more...)

- Approval Allows CGI to Access Largest National Market for Oncology Testing Services RUTHERFORD, N.J., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Cancer (read more...)

Events

05 May 15

International Society for Biological and Environmental Repositories

21 Mar 15

United States & Canadian Academy of Pathology

03 Mar 15

American Society for Clinical Pharmacology & Therapeutics (ASCPT)

Clinicians
Patients